Finance

Lists
TAK:NYSE
Takeda Pharmaceutical Co Ltd
US$18,73
+1,24%
(+0,23) 1D
US$18,80
+0,35% (+0,066)
After hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 05 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TAK...
Open
US$18,37
High
US$18,76
Low
US$18,37
Mkt. cap
59,62 ຕື້
Avg. vol.
2,37 ລ້ານ
Volume
2,04 ລ້ານ
Dividend
3,37%
Quarterly dividend
US$0,16
Ex-dividend date
29 ກ.ຍ. 2026
52-wk high
US$19,10
52-wk low
US$12,99
EPS
US$-0,33
Beta
-0,06
Shares outstanding
3,20 ຕື້
No. of employees
47 ພັນ
Open
US$18,37
High
US$18,76
Low
US$18,37
Mkt. cap
59,62 ຕື້
Avg. vol.
2,37 ລ້ານ
Volume
2,04 ລ້ານ
Dividend
3,37%
Quarterly dividend
US$0,16
Ex-dividend date
29 ກ.ຍ. 2026
52-wk high
US$19,10
52-wk low
US$12,99
EPS
US$-0,33
Beta
-0,06
Shares outstanding
3,20 ຕື້
No. of employees
47 ພັນ
News stories
From web sources and news partners
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47 ພັນ
Founded12 ມິ.ຖ. 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com
Analyst ratings
Based on 1 analyst giving stock ratings to TAK in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TAK in the last 3 months
Highest
Current US$18,73
US$42,96 (+129,37%)
Average
US$42,96 (+129,36%)
Lowest
US$42,96 (+129,37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Koichi Mamegano
Bank of America Securities
Buy
Maintained
JP¥6.800,00
+36.205,4%
09/14/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
US$21,00
+12,1%
06/04/2026
Last report
30 ກ.ລ. 2026
Fiscal period
Q1 2026
JP¥77,00 / -
0,00%miss
Revenue / Est. (JPY)
1,22 ລ້ານລ້ານ / 1,15 ລ້ານລ້ານ
+6,12%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
1,11 ລ້ານລ້ານ
1,19 ລ້ານລ້ານ
1,09 ລ້ານລ້ານ
1,22 ລ້ານລ້ານ
Cost of goods sold
380,06 ຕື້
401,15 ຕື້
453,33 ຕື້
406,68 ຕື້
Cost of revenue
380,06 ຕື້
401,15 ຕື້
453,33 ຕື້
406,68 ຕື້
Research and development expenses
161,48 ຕື້
175,23 ຕື້
187,96 ຕື້
167,40 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
253,55 ຕື້
282,78 ຕື້
291,96 ຕື້
286,51 ຕື້
Operating expense
562,57 ຕື້
661,30 ຕື້
519,65 ຕື້
612,60 ຕື້
Total operating expenses
942,63 ຕື້
1,06 ລ້ານລ້ານ
972,98 ຕື້
1,02 ລ້ານລ້ານ
Operating income
170,17 ຕື້
129,25 ຕື້
121,56 ຕື້
200,62 ຕື້
Other non operating income
77,96 ຕື້
-197,22 ຕື້
181,53 ຕື້
-28,14 ຕື້
EBT including unusual items
28,17 ຕື້
133,86 ຕື້
-455,02 ຕື້
162,72 ຕື້
EBT excluding unusual items
128,86 ຕື້
114,17 ຕື້
71,49 ຕື້
161,92 ຕື້
Income tax expense
39,90 ຕື້
30,13 ຕື້
-86,62 ຕື້
49,46 ຕື້
Effective tax rate
141,64%
22,51%
19,04%
30,40%
Other operating expenses
16,12 ຕື້
67,13 ຕື້
-64,27 ຕື້
53,17 ຕື້
Net income
-11,80 ຕື້
103,64 ຕື້
-368,47 ຕື້
113,20 ຕື້
Net profit margin
-1,06%
8,70%
-33,66%
9,28%
Earnings per share
-
-
-
-
Interest and investment income
43,92 ຕື້
181,35 ຕື້
-
24,61 ຕື້
Interest expense
-161,10 ຕື້
-
-239,63 ຕື້
-35,70 ຕື້
Net interest expenses
-117,18 ຕື້
181,35 ຕື້
-239,63 ຕື້
-11,09 ຕື້
Depreciation and amortization charges
-
-
-
-
EBITDA
355,15 ຕື້
319,89 ຕື້
192,73 ຕື້
363,66 ຕື້
Gain or loss from assets sale
303,00 ລ້ານ
358,00 ລ້ານ
1,46 ຕື້
-6,00 ຕື້
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google